PARP1 and Thrombocytopenia: Previous literature has also mentioned PARP inhibitor-induced thrombocytopenia, stating that the total incidence rate ranges from 16% to 61.3%, and the incidence of grade 3–4 thrombocytopenia (severe) is less than 1% to 33.8% (20).